Trandolapril-d3
Trandolapril-d3 is the deuterium labeled Trandolapril. Trandolapril (RU44570) is a nonsulfhydryl proagent that is hydrolysed to the active diacid Trandolaprilat. Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that has been used in the treatment of hypertension and congestive heart failure (CHF), and after myocardial infarction (MI).
Product Specifications
UNSPSC
12352005
Target
Angiotensin-converting Enzyme (ACE) ; Isotope-Labeled Compounds
Related Pathways
Metabolic Enzyme/Protease; Others
Field of Research
Cardiovascular Disease
Smiles
[H][C@@](CCCC1)(N2C([C@@H](N[C@H](CCC3=CC=CC=C3)C(OCC)=O)C([2H])([2H])[2H])=O)[C@]1(C[C@H]2C(O)=O)[H]
Molecular Formula
C24H31D3N2O5
Molecular Weight
433.56
References & Citations
[1]Peters DC, et al. Trandolapril. An update of its pharmacology and therapeutic use in cardiovascular disorders. Drugs. 1998 Nov;56 (5) :871-93.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TOR1AIP2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)
